Novel engineering efforts by a California Institute of Technology (Caltech) and Harvard University research team have yielded a tissue-engineered artificial jellyfish, dubbed Medusoid, that provides insight into the design of bioinspired

Among the vulnerabilities potentially jeopardizing U.S. dominance in the global medical device market is a “large and growing talent and development gap,” according to a recent industry analysis on Qmed’s sister site, MD+DI. But is there really a 'human talent' deficit in the U.S., or has talent just been displaced?

FDA was the subject of widespread controversy this week—but not for the usual reasons. The agency launched a "wide-ranging surveillance operation against a group of its own scientists used as an enemies list of sorts as it secretly captured thousands of e-mails that the disgruntled scientists sent privately to members of Congress, lawyers, labor officials, journalists, and even President Obama," according to the New York Times. Also this week, St.

It's been a rough year so far for St. Jude Medical's cardiac rhythm management (CRM) business, which has dealt with the high-profile Riata lead recall fallout, quelled fears about the Durata lead, launched a 'scorched-earth' campaign against Medtronic, and battled a barrage of bad press all in just a six-month period.

Researchers at Cornell University (Ithaca, NY) have developed tunable solid-state terahertz sources that employ inexpensive CMOS technology. This chip-based approach, according to the scientists, could enhance medical imaging applications and may even allow for the development of scanners capable of identifying skin cancer indicators that are invisible to the naked eye.

Although we're heading into the summer doldrums, it proved to be a relatively big week for FDA. In the wake of President Obama signing MDUFA legislation, a contributing analyst for Forbes questioned the efficacy of user fees and noted that they didn't seem to be improving productivity at the agency.

Thanks to advances in technology and the increasing ubiquity of smartphones and tablets, the global mobile health (mHealth) market is expected to reach $23 billion by 2017, according to a recent GSMA and PwC report.

During a lively roundtable discussion at the MD&M East trade show in May, renowned inventor and entrepreneur Dean Kamen didn’t hold back on the subject of current threats to medical device innovation, nor was he shy about ascribing blame—though not just to the usual suspects.

Researchers at Stanford University have developed a Jell-O-like conducting hydrogel that they claim feels and behaves similar to biological tissues but demonstrates the superior electrical conductivity of a metal or semiconductor. Quick and easy to fabricate, the material has demonstrated 'unprecedented electrical performance,' according to the researchers, and shows promise for use in future medical sensors.

While there were, of course, other newsworthy stories this week, the Supreme Court ruling on healthcare trumped them all. Read some of the highlights from the extensive media coverage and reactions from the medical device industry in our roundup below.